Literature DB >> 2175835

Expression of an antigenic polypeptide of the human parvovirus B19.

H Eiffert1, H G Köchel, M Heuer, J D Tratschin, R Thomssen.   

Abstract

The DNA fragment of the human parvovirus B19, with 715 nucleotides between nucleotide positions 3141-3856 was expressed in Escherichia coli as a beta-galactosidase fusion protein. The plasmid vector pSS20d used for this purpose permits cleavage of the viral gene product from the beta-galactosidase moiety by collagenase. After purification by p-aminophenyl-beta-D-thiogalactoside-sepharose and superose, a soluble protein with a molecular mass of 28 kDa was isolated. It represents a common part of the viral capsid proteins VP1 and VP2. This bacterially derived parvoviral gene product can be used for detection of anti-B19 antibodies in human sera.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175835     DOI: 10.1007/BF00195247

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  23 in total

1.  Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli: recognition by IgM and IgG antibodies in human sera.

Authors:  F Morinet; L D'Auriol; J D Tratschin; F Galibert
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

2.  An examination of conditions for the cleavage of polypeptide chains with cyanogen bromide: application to catalase.

Authors:  W A Schroeder; J B Shelton; J R Shelton
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

3.  Intrauterine parvovirus infection associated with hydrops fetalis.

Authors:  T Brown; A Anand; L D Ritchie; J P Clewley; T M Reid
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

4.  Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

Authors:  L J Anderson; C Tsou; R A Parker; T L Chorba; H Wulff; P Tattersall; P P Mortimer
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

5.  The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).

Authors:  T Chorba; P Coccia; R C Holman; P Tattersall; L J Anderson; J Sudman; N S Young; E Kurczynski; U M Saarinen; R Moir
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

6.  Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens.

Authors:  J P Clewley
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures.

Authors:  K Ozawa; N Young
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

8.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

9.  Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.

Authors:  S A Jenison; J M Firzlaff; A Langenberg; D A Galloway
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.